logo-loader
NYSE:ATNM

Actinium Pharmaceuticals Inc

Receive alerts
Market:
NYSE
Market Cap:
$34.17 m
Price
$0.21
Change
10.68%
52 weeks high
0.87
52 weeks low
0.19

In brief

Actinium is a leading biotechnology company developing targeted radioimmunotherapies for the treatment of cancer patients with unmet needs.